Inactive Instrument

Medivation Inc Share Price

Stocks

End-of-day quote Nasdaq
- ^USD	-

28/16/28	Eli Lilly and : Drugmaker Sanofi hungry for deals after earnings beat	RE
08/16/08	Exclusive - GW Pharmaceuticals hires investment bank following approaches: sources	RE

28/16/28	Eli Lilly and : Drugmaker Sanofi hungry for deals after earnings beat	RE
08/16/08	Exclusive - GW Pharmaceuticals hires investment bank following approaches: sources	RE
08/16/08	Abbott Laboratories : Medtech's 2016 stock surge confronts second-quarter test	RE
04/16/04	Medivation : Ex-Oppenheimer adviser arrested for trading on Pfizer employee's tips	RE
02/16/02	Medivation : sets eligibility date for shareholder consent on board revamp	RE
26/16/26	Lonza : Sanofi moves to oust Medivation board in $9.3 billion takeover fight	RE
26/16/26	Lonza : Sanofi moves to oust Medivation board in $9.3 billion takeover fight	RE
25/16/25	Exclusive: Sanofi to unveil challenge to Medivation's board - sources	RE
10/16/10	Astellas Pharma : Medivation succumbs to pressure to explore sale - sources	RE
09/16/09	Exclusive - Medivation succumbs to pressure to explore sale: sources	RE
06/16/06	Medivation : Sanofi ready to up offer for drugmaker Medivation, could oust board	RE
04/16/04	Medivation : Sanofi sees 'strong strategic' fit with U.S. Medivation	RE
04/16/04	Exclusive: Pfizer approaches Medivation about potential takeover - sources	RE

09/16/09	Medivation : New Data Presented at ESMO 2016 Further Demonstrates XTANDITM▼ (enzalutamide) Significantly Improves Time to PSA Progression in Advanced Prostate Cancer, Compared with Placebo	BU
09/16/09	Faruqi & Faruqi, LLP : Announces Filing of a Class Action Lawsuit Against Medivation, Inc.	PR
26/16/26	Brower Piven Commences An Investigation Into The Proposed Sale Of Medivation, Inc. And Encourages Shareholders To Contact The Firm For Additional Information	BU
26/16/26	Levi & Korsinsky, LLP Announces an Investigation Regarding Whether the Sale of Medivation, Inc. for $81.50 Per Share is Fair to Shareholders	BU
24/16/24	SHAREHOLDER UPDATE: Brodsky & Smith, LLC Announces an Investigation of The Board of Directors of Medivation, Inc. -MDVN	PR

28/16/28	Sanofi : relève ses prévisions pour 2016 et s'envole en Bourse
28/16/28	Sanofi : relève ses prévisions pour 2016 et veut céder ses activités génériques en Europe
10/16/10	Medivation : Neue, im Rahmen der ESMO 2016 präsentierte Ergebnisse belegen zusätzlich, dass XTANDITM▼ (Enzalutamid) die Zeit bis zur PSA-Progression bei fortgeschrittenem Prostatakarzinom im Vergleich zu Placebo signifikant verlängert
10/16/10	Medivation : De nouvelles données présentées au Congrès 2016 de l’ESMO démontrent une fois de plus que XTANDITM▼ (enzalutamide) améliore nettement, par rapport au placebo, le délai avant progression du PSA en cas de cancer de la prostate avancé
19/16/19	Sanofi : poursuit Merck en justice aux USA pour protéger les brevets de Lantus

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WUXI APPTEC CO., LTD.	+4.16%	-0.30%	+58.96%	+94.17%	7.15TCr
ARGENX SE	-0.19%	+1.32%	+37.20%	+81.33%	6.01TCr
LONZA GROUP AG	-1.51%	+2.39%	+9.10%	+36.79%	4.89TCr
IQVIA HOLDINGS INC.	+0.72%	+1.42%	+43.03%	+40.13%	4.43TCr
REVOLUTION MEDICINES, INC.	+1.59%	+8.80%	+344.39%	+693.01%	4.38TCr
BEONE MEDICINES AG	+1.87%	+2.03%	+9.31%	+108.63%	4.15TCr
CELLTRION, INC.	-0.67%	-0.45%	+4.47%	+46.37%	3.01TCr
WUXI BIOLOGICS (CAYMAN) INC.	+4.77%	+6.46%	+41.54%	+22.78%	2.8TCr
INSMED INCORPORATED	+0.25%	-1.78%	-19.29%	+358.14%	2.53TCr
Average	+1.27%	+0.48%	+58.75%	+164.59%	4.37TCr
Weighted average by Cap.	+1.35%	+0.63%	+63.77%	+155.43%